AstraZeneca vaccine: Germany disagrees with EU on Blood clot.

By Ann Mary Kisakye

Updated at 17:05 GMT on Friday 12th March 21

Germany’s health minister disagrees with several European countries suspending the AstraZeneca vaccine rollout, saying the “benefit is far greater than the risk.”

The Health Minister Jens Spahn said Friday there is no evidence of an increase in blood clots in connection with the AstraZeneca COVID vaccine.

Germany Health Minister Jens Spahn

Spahn’s comments come after Denmark and several other European countries suspended the AstraZeneca vaccine’s rollout over reports of people developing severe thrombosis after receiving a dose. 

What Jens Spahn, and others, said about AstraZeneca

The health minister spoke after consulting with experts at the European Medicines Agency (EMA), which has approved the shot for use in the EU.


“I regret that … some countries in the European Union have suspended vaccination with AstraZeneca,” Spahn said, adding that Germany takes possible side effects “very seriously.”

“From what we know so far, the benefit … is far greater than the risk,” he added.

The EMA said in a statement Thursday that information available so far indicates that the number severe blood clotting events in vaccinated people is “no higher than that seen in the general population.”

“There is currently no indication that vaccination has caused these conditions,” the statement said.

The World Health Organization (WHO) said Friday that the vaccine is safe.

AstraZeneca has an “excellent vaccine, as are the other vaccines that are being used,” WHO spokeswoman Margaret Harris told reporters at a briefing in Geneva.

Why did European countries suspend use?

Denmark halted using the vaccine on Thursday as a “precautionary” principle after one person who had received a dose of the vaccine developed a blood clot and died. Several other countries, including Norway and Italy, followed suit soon after.


Austria suspended use of an AstraZeneca vaccine batch after a person died from “severe blood coagulation problems” following vaccination.

On Friday, Bulgaria halted use of the vaccine over safety concerns, although the health ministry said no severe side effects had been reported in the country thus far. Bulgaria has the lowest vaccination rate in the EU and relies primarily on the AstraZeneca vaccine.

Bulgarian Prime Minister Boyko Borisov said that vaccinations would be halted until the EMA issued Bulgaria a “written statement” with a “clearly confirmed diagnosis” that the vaccine is safe to administer.

The EU has struggled so far with its COVID vaccination rollout, suffering with delivery delays from vaccine suppliers and bureaucratic hurdles.

The EU has so far approved vaccines from BioNTech-Pfizer, Moderna, and AstraZeneca, with Johnson & Johnson’s single-dose vaccine added to the list Friday.

Additional reporting by DW


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s